Zurich Cantonal Bank’s MyoKardia, Inc. Common Stock MYOK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
– Sell
-5,630
Closed -$768K – 2654
2020
Q3
$768K Hold
5,630
– – 0.01% 918
2020
Q2
$544K Buy
5,630
+1,868
+50% +$156K ﹤0.01% 973
2020
Q1
$176K Buy
3,762
+380
+11% +$24.4K ﹤0.01% 1290
2019
Q4
$246K Hold
3,382
– – ﹤0.01% 1228
2019
Q3
$176K Buy
3,382
+579
+21% +$30.8K ﹤0.01% 1306
2019
Q2
$141K Buy
2,803
+791
+39% +$38.5K ﹤0.01% 1430
2019
Q1
$105K Hold
2,012
– – ﹤0.01% 1556
2018
Q4
$98K Hold
2,012
– – ﹤0.01% 1614
2018
Q3
$131K Hold
2,012
– – ﹤0.01% 1560
2018
Q2
$100K Buy
2,012
+662
+49% +$32K ﹤0.01% 1649
2018
Q1
$66K Buy
1,350
+980
+265% +$50.9K ﹤0.01% 1864
2017
Q4
$16K Buy
+370
New +$14.3K ﹤0.01% 2450

Zurich Cantonal Bank's MYOK Position: Q4 2020 in Review

Zurich Cantonal Bank sold out of MyoKardia, Inc. Common Stock (MYOK) in Q4 2020, closing a stake of 5,630 shares — an estimated $768K sold.

Zurich Cantonal Bank first reported a position in MYOK in Q4 2017 and held it in 12 quarters. The position peaked at $768K in Q3 2020. 0 funds tracked by Wall St. Rank hold MYOK as of Q4 2020.

  • Zurich Cantonal Bank reported no remaining MyoKardia, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
  • Zurich Cantonal Bank sold 5,630 MyoKardia, Inc. Common Stock shares in Q4 2020, an estimated $768K.
  • Zurich Cantonal Bank first reported a position in MyoKardia, Inc. Common Stock in Q4 2017 and held it in 12 quarters.
  • Zurich Cantonal Bank's MyoKardia, Inc. Common Stock position peaked at $768K in Q3 2020.
  • 0 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q4 2020.

Based on Zurich Cantonal Bank's 13F filing for Q4 2020, filed 28 Jan 2021.